Concepedia

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Suzanne Leijen, Sjaak A. Burgers, Dick Pluim, Matthijs M. Tibben, Erik van Werkhoven, Enzo Alessio, Gianni Sava, Jos H. Beijnen, Jan H.M. Schellens

Investigational New Drugs · 2014 · 366 citations · 51 references

DOIFull text

Open access

Concepts

References

51

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Design and Analysis of Phase I Clinical Trials

Barry E. Storer · Biometrics · 1989 · 932 citations

, , +9

A Phase I and Pharmacological Study with Imidazolium-<b> <i>trans-</i> </b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research · 2004 · 823 citations · Full text

, , +12

Ruthenium in Medicine: Current Clinical Uses and Future Prospects

Claire S. Allardyce, Paul J. Dyson · Platinum Metals Review · 2001 · 541 citations · Full text

, , +13